SlideShare a Scribd company logo
Dementias & Neurodegenerative
Diseases Research Network
“Is there a patient in the house?
- public involvement in research”
Simon Denegri
NIHR National Director for Public Participation and Engagement in Research
Patient participation in NHS
research
Public appetite
• 82 % of people believe it is important
for the NHS to offer opportunities to
take part in healthcare research.
NIHR Clinical Research Networks Survey May 2012
• 81% are willing to get involved in
dementia research
• 76% of people believe experiences
of patients and carers could be
important for shaping research
studies.
YouGov for Alzheimer's Research UK 2013
Patient experience
• 91% of Trusts do not provide
information to support patient
choice in research
NIHR CRN CC Mystery Shopper 2013
• 34% of respondents did not know
enough about what participating
in research would involve - and
this % is slightly higher amongst
older age groups
• Very few people appear to know
someone who has taken part in
research
YouGov for Alzheimer's Research UK 2013
Dementias & Neurodegenerative
Diseases Research Network
Policy, legislative and
organisational framework
• Life Sciences Strategy
• Health and Social Care Act 2012
• NHS Choice Framework
• NHS Constitution; use of medical records in research
• Organisations: CCGs, Healthwatch, DeNDRoN, Academic
Health Science Networks (AHSNs)
“Patient experience is the most important concern for the
NHS Commissioning Board”
Sir Malcolm Grant , Chair, NHSCB
Dementias & Neurodegenerative
Diseases Research Network
Reasoning for taking part –
THE EVIDENCE
• Can improve quality of life / treatment
• Altruistic motives
• Interaction between study coordinators and
patient/carers
Dementias & Neurodegenerative
Diseases Research Network
How can you can get involved?
• Taking part by participating in
a clinical research study
• Becoming a member of a
patient research group to
share your views on our
research ideas.
Dementias & Neurodegenerative
Diseases Research Network
“We want more people into clinical trials;
more people getting that chance to get the
very latest drugs. Our ambition is this: at
least 10 per cent of people with dementia
should be able to take part in clinical trials
– up around ten times from today”
March 26 2012: Prime Minister’s Challenge on Dementia: Delivering
major improvements in dementia care and research by 2015
“
“
665,065
People estimated to
be living with
dementia in
England
4% Of people with
dementia were involved
in a dementia-related
study in 2012
The challenge
Dementias & Neurodegenerative
Diseases Research Network
Challenge areas
• Increasing willingness
• Enabling patient choice
• Involving patients from the beginning
• Seeing research as a key driver of quality
• Putting a human face on data to inform choice and
improve health
“Every patient who
walks through our
hospital doors is offered
the chance to take part
in a clinical trial”
I was able to
refer myself to a
clinical trial unit
They told myself
and other
patients what
they found out in
the trial before
anyone else.
It was easy for
me to find out
what’s going
on locally
I was able to
discuss taking
part in research
with my doctor
shortly after I
was diagnosed
I feel as though I
was able to make a
difference
Patients can talk
to other patients
in our Trust to
find out more
about research
My care and
treatment was
of a higher
quality
I joined the
national register
for research
First I took
part and now I
help design
trials. How
good is that?
Dementias & Neurodegenerative
Diseases Research Network
Patient-driven access
• Vision will be achieved by patients and the
public:
– Asking about research
– Choosing to take part in research
– Knowing their contribution has made a difference
– Shaping the way in which research is designed and
delivered
– Leading change at local and national level to make
research happen
– Reporting on and sharing their experiences with
commissioners and providers
Dementias & Neurodegenerative
Diseases Research Network
Campaigns helping us deliver the
research agenda…
International
Clinical Trials
Day (ICTD):
20th May 2013
Dementias & Neurodegenerative
Diseases Research Network
Patients in Research infokit
A platform to share stories, ideas,
tips and tools to embed research
across the NHS.
www.patientsinresearch.org
EXPLORE
CREATE
TELL US
how others are integrating
research into care
your own strategy to embed
research
about your initiative no
matter what your disease
area
What can you do?
Get research on the
agenda
2
Support “It’s OK to ask”
campaign
1
Sign up to DeNDRoN
community
3
Dementias & Neurodegenerative
Diseases Research Network
Want to know more?
Visit: www.dendron.nihr.ac.uk
Email: info@dendron.org.uk
Phone: 020 3206 4960

More Related Content

What's hot

Patient involvement in medicines development – the views of patients and key ...
Patient involvement in medicines development – the views of patients and key ...Patient involvement in medicines development – the views of patients and key ...
Patient involvement in medicines development – the views of patients and key ...
Nowgen
 
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
Nowgen
 
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
Nowgen
 
Professor Kamlesh Khunti - Prevention of Chronic Disease
Professor Kamlesh Khunti - Prevention of Chronic DiseaseProfessor Kamlesh Khunti - Prevention of Chronic Disease
Professor Kamlesh Khunti - Prevention of Chronic Disease
CLAHRC-NDL
 
Bringing the patient voice into GSK for educational, awareness and patient ce...
Bringing the patient voice into GSK for educational, awareness and patient ce...Bringing the patient voice into GSK for educational, awareness and patient ce...
Bringing the patient voice into GSK for educational, awareness and patient ce...
Nowgen
 
Professor Richard Morriss - Enhancing Mental Health
Professor Richard Morriss - Enhancing Mental HealthProfessor Richard Morriss - Enhancing Mental Health
Professor Richard Morriss - Enhancing Mental Health
CLAHRC-NDL
 
Patients at the Centre for Health Research – Patient, Carer and Public Invol...
Patients at the Centre for Health Research –  Patient, Carer and Public Invol...Patients at the Centre for Health Research –  Patient, Carer and Public Invol...
Patients at the Centre for Health Research – Patient, Carer and Public Invol...
Nowgen
 
HSRN workshop simon denegri - 18th June 2013
HSRN workshop   simon denegri - 18th June 2013HSRN workshop   simon denegri - 18th June 2013
HSRN workshop simon denegri - 18th June 2013
Simon Denegri
 
Judith Carrier_LTC Consensus Meeting 10-Nov-2015
Judith Carrier_LTC Consensus Meeting 10-Nov-2015Judith Carrier_LTC Consensus Meeting 10-Nov-2015
Judith Carrier_LTC Consensus Meeting 10-Nov-2015
angewatkins
 
Co-design, Co-produce, Co-deliver: Collaboration is the only viable path to s...
Co-design, Co-produce, Co-deliver: Collaboration is the only viable path to s...Co-design, Co-produce, Co-deliver: Collaboration is the only viable path to s...
Co-design, Co-produce, Co-deliver: Collaboration is the only viable path to s...
Simon R. Stones
 
CER 2016 Jacoby stakeholder engagement
CER 2016 Jacoby stakeholder engagementCER 2016 Jacoby stakeholder engagement
CER 2016 Jacoby stakeholder engagement
CTSI at UCSF
 
Member experiences in an Australian Translational Cancer Research Centre and ...
Member experiences in an Australian Translational Cancer Research Centre and ...Member experiences in an Australian Translational Cancer Research Centre and ...
Member experiences in an Australian Translational Cancer Research Centre and ...
Cancer Institute NSW
 
Patient involvement in clinical research and long term conditions -what can b...
Patient involvement in clinical research and long term conditions -what can b...Patient involvement in clinical research and long term conditions -what can b...
Patient involvement in clinical research and long term conditions -what can b...
Nowgen
 
Nefyn Williams_LTC Consensus Meeting 10-Nov-2015
Nefyn Williams_LTC Consensus Meeting 10-Nov-2015 Nefyn Williams_LTC Consensus Meeting 10-Nov-2015
Nefyn Williams_LTC Consensus Meeting 10-Nov-2015
angewatkins
 
Closing the Perception Gap
Closing the Perception GapClosing the Perception Gap
Closing the Perception Gap
Health and Care Innovation Expo
 
Ensuring research really does involve the young person
Ensuring research really does involve the young personEnsuring research really does involve the young person
Ensuring research really does involve the young person
Simon R. Stones
 
CER 2016 Dohan EQUIP
CER 2016 Dohan EQUIPCER 2016 Dohan EQUIP
CER 2016 Dohan EQUIP
CTSI at UCSF
 
DeNDRoN Presentation December 2012
DeNDRoN Presentation December 2012DeNDRoN Presentation December 2012
DeNDRoN Presentation December 2012
DeNDRoN-Comms
 
CER 2016 Trontell pcori cer presentation 2016 02 02 final
CER 2016 Trontell pcori cer presentation 2016 02 02 finalCER 2016 Trontell pcori cer presentation 2016 02 02 final
CER 2016 Trontell pcori cer presentation 2016 02 02 final
CTSI at UCSF
 
Itamar Medical
Itamar MedicalItamar Medical

What's hot (20)

Patient involvement in medicines development – the views of patients and key ...
Patient involvement in medicines development – the views of patients and key ...Patient involvement in medicines development – the views of patients and key ...
Patient involvement in medicines development – the views of patients and key ...
 
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
 
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
 
Professor Kamlesh Khunti - Prevention of Chronic Disease
Professor Kamlesh Khunti - Prevention of Chronic DiseaseProfessor Kamlesh Khunti - Prevention of Chronic Disease
Professor Kamlesh Khunti - Prevention of Chronic Disease
 
Bringing the patient voice into GSK for educational, awareness and patient ce...
Bringing the patient voice into GSK for educational, awareness and patient ce...Bringing the patient voice into GSK for educational, awareness and patient ce...
Bringing the patient voice into GSK for educational, awareness and patient ce...
 
Professor Richard Morriss - Enhancing Mental Health
Professor Richard Morriss - Enhancing Mental HealthProfessor Richard Morriss - Enhancing Mental Health
Professor Richard Morriss - Enhancing Mental Health
 
Patients at the Centre for Health Research – Patient, Carer and Public Invol...
Patients at the Centre for Health Research –  Patient, Carer and Public Invol...Patients at the Centre for Health Research –  Patient, Carer and Public Invol...
Patients at the Centre for Health Research – Patient, Carer and Public Invol...
 
HSRN workshop simon denegri - 18th June 2013
HSRN workshop   simon denegri - 18th June 2013HSRN workshop   simon denegri - 18th June 2013
HSRN workshop simon denegri - 18th June 2013
 
Judith Carrier_LTC Consensus Meeting 10-Nov-2015
Judith Carrier_LTC Consensus Meeting 10-Nov-2015Judith Carrier_LTC Consensus Meeting 10-Nov-2015
Judith Carrier_LTC Consensus Meeting 10-Nov-2015
 
Co-design, Co-produce, Co-deliver: Collaboration is the only viable path to s...
Co-design, Co-produce, Co-deliver: Collaboration is the only viable path to s...Co-design, Co-produce, Co-deliver: Collaboration is the only viable path to s...
Co-design, Co-produce, Co-deliver: Collaboration is the only viable path to s...
 
CER 2016 Jacoby stakeholder engagement
CER 2016 Jacoby stakeholder engagementCER 2016 Jacoby stakeholder engagement
CER 2016 Jacoby stakeholder engagement
 
Member experiences in an Australian Translational Cancer Research Centre and ...
Member experiences in an Australian Translational Cancer Research Centre and ...Member experiences in an Australian Translational Cancer Research Centre and ...
Member experiences in an Australian Translational Cancer Research Centre and ...
 
Patient involvement in clinical research and long term conditions -what can b...
Patient involvement in clinical research and long term conditions -what can b...Patient involvement in clinical research and long term conditions -what can b...
Patient involvement in clinical research and long term conditions -what can b...
 
Nefyn Williams_LTC Consensus Meeting 10-Nov-2015
Nefyn Williams_LTC Consensus Meeting 10-Nov-2015 Nefyn Williams_LTC Consensus Meeting 10-Nov-2015
Nefyn Williams_LTC Consensus Meeting 10-Nov-2015
 
Closing the Perception Gap
Closing the Perception GapClosing the Perception Gap
Closing the Perception Gap
 
Ensuring research really does involve the young person
Ensuring research really does involve the young personEnsuring research really does involve the young person
Ensuring research really does involve the young person
 
CER 2016 Dohan EQUIP
CER 2016 Dohan EQUIPCER 2016 Dohan EQUIP
CER 2016 Dohan EQUIP
 
DeNDRoN Presentation December 2012
DeNDRoN Presentation December 2012DeNDRoN Presentation December 2012
DeNDRoN Presentation December 2012
 
CER 2016 Trontell pcori cer presentation 2016 02 02 final
CER 2016 Trontell pcori cer presentation 2016 02 02 finalCER 2016 Trontell pcori cer presentation 2016 02 02 final
CER 2016 Trontell pcori cer presentation 2016 02 02 final
 
Itamar Medical
Itamar MedicalItamar Medical
Itamar Medical
 

Viewers also liked

Flash Allocation d'Actifs : le « Bull Market » est challengé sur ses 3 pilier...
Flash Allocation d'Actifs : le « Bull Market » est challengé sur ses 3 pilier...Flash Allocation d'Actifs : le « Bull Market » est challengé sur ses 3 pilier...
Flash Allocation d'Actifs : le « Bull Market » est challengé sur ses 3 pilier...
OFI Asset Management
 
Inside look at a making of a mural 3
Inside look at a making of a mural 3Inside look at a making of a mural 3
Inside look at a making of a mural 3
chimz12
 
Andamio cognitivo
Andamio cognitivoAndamio cognitivo
Andamio cognitivo
catalina prieto
 
Istanbul IETT Professional Development Workshop, #4 of 6_Transit & Land Use
Istanbul IETT Professional Development Workshop, #4 of 6_Transit & Land UseIstanbul IETT Professional Development Workshop, #4 of 6_Transit & Land Use
Istanbul IETT Professional Development Workshop, #4 of 6_Transit & Land Use
VTPI
 
【静岡ブロック】UDC2015(20140622)
【静岡ブロック】UDC2015(20140622)【静岡ブロック】UDC2015(20140622)
【静岡ブロック】UDC2015(20140622)
Hitoshi Sugimoto
 
V Concurs Fotogràfic Francesc Boix 2014. Obres seleccionades i guanyadores. B...
V Concurs Fotogràfic Francesc Boix 2014. Obres seleccionades i guanyadores. B...V Concurs Fotogràfic Francesc Boix 2014. Obres seleccionades i guanyadores. B...
V Concurs Fotogràfic Francesc Boix 2014. Obres seleccionades i guanyadores. B...
Biblioteca Poble-sec - Francesc Boix
 
Técnicas procura emprego apresentaçao cv
Técnicas procura emprego apresentaçao   cvTécnicas procura emprego apresentaçao   cv
Técnicas procura emprego apresentaçao cv
João Pedro Ferreira Silva
 
OracleSOA11gSales Specialist
OracleSOA11gSales SpecialistOracleSOA11gSales Specialist
OracleSOA11gSales Specialist
SivaRam Appali
 
OracleSOA11gImplementation
OracleSOA11gImplementationOracleSOA11gImplementation
OracleSOA11gImplementation
SivaRam Appali
 
Teoria de la forma
Teoria de la formaTeoria de la forma
Teoria de la forma
wuilsong09
 
Animar o empreendedorismo
Animar o empreendedorismoAnimar o empreendedorismo
Animar o empreendedorismo
João Pedro Ferreira Silva
 
OracleSOA11gPreSales Specialist
OracleSOA11gPreSales SpecialistOracleSOA11gPreSales Specialist
OracleSOA11gPreSales Specialist
SivaRam Appali
 

Viewers also liked (12)

Flash Allocation d'Actifs : le « Bull Market » est challengé sur ses 3 pilier...
Flash Allocation d'Actifs : le « Bull Market » est challengé sur ses 3 pilier...Flash Allocation d'Actifs : le « Bull Market » est challengé sur ses 3 pilier...
Flash Allocation d'Actifs : le « Bull Market » est challengé sur ses 3 pilier...
 
Inside look at a making of a mural 3
Inside look at a making of a mural 3Inside look at a making of a mural 3
Inside look at a making of a mural 3
 
Andamio cognitivo
Andamio cognitivoAndamio cognitivo
Andamio cognitivo
 
Istanbul IETT Professional Development Workshop, #4 of 6_Transit & Land Use
Istanbul IETT Professional Development Workshop, #4 of 6_Transit & Land UseIstanbul IETT Professional Development Workshop, #4 of 6_Transit & Land Use
Istanbul IETT Professional Development Workshop, #4 of 6_Transit & Land Use
 
【静岡ブロック】UDC2015(20140622)
【静岡ブロック】UDC2015(20140622)【静岡ブロック】UDC2015(20140622)
【静岡ブロック】UDC2015(20140622)
 
V Concurs Fotogràfic Francesc Boix 2014. Obres seleccionades i guanyadores. B...
V Concurs Fotogràfic Francesc Boix 2014. Obres seleccionades i guanyadores. B...V Concurs Fotogràfic Francesc Boix 2014. Obres seleccionades i guanyadores. B...
V Concurs Fotogràfic Francesc Boix 2014. Obres seleccionades i guanyadores. B...
 
Técnicas procura emprego apresentaçao cv
Técnicas procura emprego apresentaçao   cvTécnicas procura emprego apresentaçao   cv
Técnicas procura emprego apresentaçao cv
 
OracleSOA11gSales Specialist
OracleSOA11gSales SpecialistOracleSOA11gSales Specialist
OracleSOA11gSales Specialist
 
OracleSOA11gImplementation
OracleSOA11gImplementationOracleSOA11gImplementation
OracleSOA11gImplementation
 
Teoria de la forma
Teoria de la formaTeoria de la forma
Teoria de la forma
 
Animar o empreendedorismo
Animar o empreendedorismoAnimar o empreendedorismo
Animar o empreendedorismo
 
OracleSOA11gPreSales Specialist
OracleSOA11gPreSales SpecialistOracleSOA11gPreSales Specialist
OracleSOA11gPreSales Specialist
 

Similar to Simon denegri bristol-website

Alberta 2015
Alberta 2015Alberta 2015
Alberta 2015
Simon Denegri
 
The value off engaging patients in research
The value off engaging patients in researchThe value off engaging patients in research
The value off engaging patients in research
Simon Denegri
 
Isn't this about me? The role of patients and the public in implementing evid...
Isn't this about me? The role of patients and the public in implementing evid...Isn't this about me? The role of patients and the public in implementing evid...
Isn't this about me? The role of patients and the public in implementing evid...
NEQOS
 
2019 IPPOSI membership survey results
2019 IPPOSI membership survey results2019 IPPOSI membership survey results
2019 IPPOSI membership survey results
ipposi
 
National overview learning disabilities
National overview  learning disabilitiesNational overview  learning disabilities
National overview learning disabilities
NHS Improving Quality
 
Presentation to National Institute for Health Research (NIHR) Public Involvem...
Presentation to National Institute for Health Research (NIHR) Public Involvem...Presentation to National Institute for Health Research (NIHR) Public Involvem...
Presentation to National Institute for Health Research (NIHR) Public Involvem...
Simon Denegri
 
Cure care and research in English dementia policy
Cure care and research in English dementia policyCure care and research in English dementia policy
Cure care and research in English dementia policy
shibley
 
Patient, carer & public involvement in clinical guidelines: the NICE experience
Patient, carer & public involvement in clinical guidelines: the NICE experiencePatient, carer & public involvement in clinical guidelines: the NICE experience
Patient, carer & public involvement in clinical guidelines: the NICE experience
GuíaSalud
 
Would knowing your genetic risk for dementia change the way you behave with t...
Would knowing your genetic risk for dementia change the way you behave with t...Would knowing your genetic risk for dementia change the way you behave with t...
Would knowing your genetic risk for dementia change the way you behave with t...
shibley
 
Digital Health Technology: The Ultimate Patient Advocate
Digital Health Technology: The Ultimate Patient AdvocateDigital Health Technology: The Ultimate Patient Advocate
Digital Health Technology: The Ultimate Patient Advocate
David Lee Scher, MD
 
Newhouse arkansas 4-7-14(v2)
Newhouse arkansas 4-7-14(v2)Newhouse arkansas 4-7-14(v2)
Newhouse arkansas 4-7-14(v2)
TRIuams
 
Quantified Self: Helping Physicians Empower Their Patients
Quantified Self: Helping Physicians Empower Their PatientsQuantified Self: Helping Physicians Empower Their Patients
Quantified Self: Helping Physicians Empower Their Patients
Social Media Today
 
Zoë Gray: INVOLVE: Learning from 21 years at the helm of public involvement
Zoë Gray: INVOLVE: Learning from 21 years at the helm of public involvementZoë Gray: INVOLVE: Learning from 21 years at the helm of public involvement
Zoë Gray: INVOLVE: Learning from 21 years at the helm of public involvement
koradk
 
8,766 days to change a life
8,766 days to change a life8,766 days to change a life
8,766 days to change a life
Simon R. Stones
 
APA 2015_LM Brady involving cyp in research_03.15
APA 2015_LM Brady involving cyp in research_03.15APA 2015_LM Brady involving cyp in research_03.15
APA 2015_LM Brady involving cyp in research_03.15
Louca-Mai Brady
 
Factors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MHFactors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MH
michaela naicker
 
Power to the Patient
Power to the PatientPower to the Patient
Power to the Patient
Bastian Greshake
 
One London conversation workshop 18 July slide deck
One London conversation workshop 18 July slide deck One London conversation workshop 18 July slide deck
One London conversation workshop 18 July slide deck
Katie Harrison
 
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
Human Variome Project
 
PE101 Introduction to Patient Engagement
PE101 Introduction to Patient EngagementPE101 Introduction to Patient Engagement
PE101 Introduction to Patient Engagement
CHICommunications
 

Similar to Simon denegri bristol-website (20)

Alberta 2015
Alberta 2015Alberta 2015
Alberta 2015
 
The value off engaging patients in research
The value off engaging patients in researchThe value off engaging patients in research
The value off engaging patients in research
 
Isn't this about me? The role of patients and the public in implementing evid...
Isn't this about me? The role of patients and the public in implementing evid...Isn't this about me? The role of patients and the public in implementing evid...
Isn't this about me? The role of patients and the public in implementing evid...
 
2019 IPPOSI membership survey results
2019 IPPOSI membership survey results2019 IPPOSI membership survey results
2019 IPPOSI membership survey results
 
National overview learning disabilities
National overview  learning disabilitiesNational overview  learning disabilities
National overview learning disabilities
 
Presentation to National Institute for Health Research (NIHR) Public Involvem...
Presentation to National Institute for Health Research (NIHR) Public Involvem...Presentation to National Institute for Health Research (NIHR) Public Involvem...
Presentation to National Institute for Health Research (NIHR) Public Involvem...
 
Cure care and research in English dementia policy
Cure care and research in English dementia policyCure care and research in English dementia policy
Cure care and research in English dementia policy
 
Patient, carer & public involvement in clinical guidelines: the NICE experience
Patient, carer & public involvement in clinical guidelines: the NICE experiencePatient, carer & public involvement in clinical guidelines: the NICE experience
Patient, carer & public involvement in clinical guidelines: the NICE experience
 
Would knowing your genetic risk for dementia change the way you behave with t...
Would knowing your genetic risk for dementia change the way you behave with t...Would knowing your genetic risk for dementia change the way you behave with t...
Would knowing your genetic risk for dementia change the way you behave with t...
 
Digital Health Technology: The Ultimate Patient Advocate
Digital Health Technology: The Ultimate Patient AdvocateDigital Health Technology: The Ultimate Patient Advocate
Digital Health Technology: The Ultimate Patient Advocate
 
Newhouse arkansas 4-7-14(v2)
Newhouse arkansas 4-7-14(v2)Newhouse arkansas 4-7-14(v2)
Newhouse arkansas 4-7-14(v2)
 
Quantified Self: Helping Physicians Empower Their Patients
Quantified Self: Helping Physicians Empower Their PatientsQuantified Self: Helping Physicians Empower Their Patients
Quantified Self: Helping Physicians Empower Their Patients
 
Zoë Gray: INVOLVE: Learning from 21 years at the helm of public involvement
Zoë Gray: INVOLVE: Learning from 21 years at the helm of public involvementZoë Gray: INVOLVE: Learning from 21 years at the helm of public involvement
Zoë Gray: INVOLVE: Learning from 21 years at the helm of public involvement
 
8,766 days to change a life
8,766 days to change a life8,766 days to change a life
8,766 days to change a life
 
APA 2015_LM Brady involving cyp in research_03.15
APA 2015_LM Brady involving cyp in research_03.15APA 2015_LM Brady involving cyp in research_03.15
APA 2015_LM Brady involving cyp in research_03.15
 
Factors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MHFactors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MH
 
Power to the Patient
Power to the PatientPower to the Patient
Power to the Patient
 
One London conversation workshop 18 July slide deck
One London conversation workshop 18 July slide deck One London conversation workshop 18 July slide deck
One London conversation workshop 18 July slide deck
 
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...
 
PE101 Introduction to Patient Engagement
PE101 Introduction to Patient EngagementPE101 Introduction to Patient Engagement
PE101 Introduction to Patient Engagement
 

Simon denegri bristol-website

  • 1. Dementias & Neurodegenerative Diseases Research Network “Is there a patient in the house? - public involvement in research” Simon Denegri NIHR National Director for Public Participation and Engagement in Research
  • 2. Patient participation in NHS research Public appetite • 82 % of people believe it is important for the NHS to offer opportunities to take part in healthcare research. NIHR Clinical Research Networks Survey May 2012 • 81% are willing to get involved in dementia research • 76% of people believe experiences of patients and carers could be important for shaping research studies. YouGov for Alzheimer's Research UK 2013 Patient experience • 91% of Trusts do not provide information to support patient choice in research NIHR CRN CC Mystery Shopper 2013 • 34% of respondents did not know enough about what participating in research would involve - and this % is slightly higher amongst older age groups • Very few people appear to know someone who has taken part in research YouGov for Alzheimer's Research UK 2013
  • 3. Dementias & Neurodegenerative Diseases Research Network Policy, legislative and organisational framework • Life Sciences Strategy • Health and Social Care Act 2012 • NHS Choice Framework • NHS Constitution; use of medical records in research • Organisations: CCGs, Healthwatch, DeNDRoN, Academic Health Science Networks (AHSNs) “Patient experience is the most important concern for the NHS Commissioning Board” Sir Malcolm Grant , Chair, NHSCB
  • 4. Dementias & Neurodegenerative Diseases Research Network Reasoning for taking part – THE EVIDENCE • Can improve quality of life / treatment • Altruistic motives • Interaction between study coordinators and patient/carers
  • 5. Dementias & Neurodegenerative Diseases Research Network How can you can get involved? • Taking part by participating in a clinical research study • Becoming a member of a patient research group to share your views on our research ideas.
  • 6. Dementias & Neurodegenerative Diseases Research Network “We want more people into clinical trials; more people getting that chance to get the very latest drugs. Our ambition is this: at least 10 per cent of people with dementia should be able to take part in clinical trials – up around ten times from today” March 26 2012: Prime Minister’s Challenge on Dementia: Delivering major improvements in dementia care and research by 2015 “ “
  • 7. 665,065 People estimated to be living with dementia in England 4% Of people with dementia were involved in a dementia-related study in 2012 The challenge
  • 8. Dementias & Neurodegenerative Diseases Research Network Challenge areas • Increasing willingness • Enabling patient choice • Involving patients from the beginning • Seeing research as a key driver of quality • Putting a human face on data to inform choice and improve health
  • 9. “Every patient who walks through our hospital doors is offered the chance to take part in a clinical trial” I was able to refer myself to a clinical trial unit They told myself and other patients what they found out in the trial before anyone else. It was easy for me to find out what’s going on locally I was able to discuss taking part in research with my doctor shortly after I was diagnosed I feel as though I was able to make a difference Patients can talk to other patients in our Trust to find out more about research My care and treatment was of a higher quality I joined the national register for research First I took part and now I help design trials. How good is that?
  • 10. Dementias & Neurodegenerative Diseases Research Network Patient-driven access • Vision will be achieved by patients and the public: – Asking about research – Choosing to take part in research – Knowing their contribution has made a difference – Shaping the way in which research is designed and delivered – Leading change at local and national level to make research happen – Reporting on and sharing their experiences with commissioners and providers
  • 11. Dementias & Neurodegenerative Diseases Research Network Campaigns helping us deliver the research agenda…
  • 13.
  • 14. Dementias & Neurodegenerative Diseases Research Network Patients in Research infokit A platform to share stories, ideas, tips and tools to embed research across the NHS. www.patientsinresearch.org EXPLORE CREATE TELL US how others are integrating research into care your own strategy to embed research about your initiative no matter what your disease area
  • 15. What can you do? Get research on the agenda 2 Support “It’s OK to ask” campaign 1 Sign up to DeNDRoN community 3
  • 16. Dementias & Neurodegenerative Diseases Research Network Want to know more? Visit: www.dendron.nihr.ac.uk Email: info@dendron.org.uk Phone: 020 3206 4960

Editor's Notes

  1. Presentation will coverWhat is your right?What you can do as a patient to get involved in clinical research? How this will help shape the future of dementia?
  2. Improve quality of life / treat disease The most important reason given by carers was direct medical benefit to the patient, help the relative feel better and even to cure their ADIn one survey, several caregivers stated that a sense of desperation they felt about finding help for their relative motivated their enrolment, but this feeling of desperation was low on the list of reasons(Mastwyk, Ritchie et al. 2002; Mastwyk, Macfarlane et al. 2003) (Lynoe, Sandlund et al. 1991; Karlawish, Casarett et al. 2001)Altruistic motivesbelief that participation benefits others in future cited by one participant was that they cannot leave money to the university but can help by contributing to research (Lynoe, Sandlund et al. 1991; Morrow, Hickok et al. 1994; Connell, Shaw et al. 2001; Mastwyk, Ritchie et al. 2002; Mastwyk, Macfarlane et al. 2003)Interaction between study coordinators and patient/carersTrust in doctor and their medical knowledge is another common reason for one to participate in clinical studies in general (Geston and Mcvamara 1984)Some participants report that enrolling in a clinical study gets the patient more medical attention and that the medical system takes better care of you when you participate (Connell and Gallant 1996)Although there was no change physically or emotionally to the patient as a result of participating, majority of carers felt that participation was a positive experience
  3. Patients are at the centre of what we do. As a patient, carer or a member of the public you can help research.By being involved in a ‘research patient group’ your help will ensure we continue to deliver exceptional healthcare now and in the future.You don't need any research experience. People with personal experience of healthcare are best placed to comment on what research is needed and how research should be done.Members of the public can bring a different perspective that is not always the same as those of researchers. Your involvement helps to ensure that the process is focused on what is important to people making it more relevant and acceptable to people who need to use our services.For example……being part of a research patient panel you will be able to:Comment on researchers’ treatment ideasComment on how treatment will be carried outRead and give feedback on patient information sheets, letters to patients and questionnairesParticipate in Research Committees and Research Project Meetings
  4. 2 key pointsPM challenge – This is a Government priority10% ambitionPatient and public involvement throughout
  5. Currently only 4% of patients are involved in research, but we are aiming for 10%, so there is a lot more work yet that needs to be done….This is where you (audience) come in…… we need every trust to get research on the agenda, we every patient and carer asking their clinician or nurse, every health profession asking their patients, and signing up to research.
  6. Patient pull-through increasing willingness to take part in clinical researchEnabling patient choice in research as part of the care pathwayResponding to the patient challenge over how research is conducted and their part in itEncouraging NHS leadership and culture to see research as a key driver of qualityInformation-sharing, transparency and openness: putting a human face on data to inform choice and improve health
  7. Collaborative working to:Supporting patient choiceDefining and diffusing models of public involvement that drive participationImproving public awareness and understandingLearning from patient insight and experience Supporting patient and organisational leadership
  8. Key messagesWhat we want people to doHow they can help
  9. Initiatives like Patients in Research are trying to get research on the agenda of every organisation:Research should be a core part of any care pathway.The infokit is a platform to share ideas and practice: showcase work from across the NHS and research community to improve patient participation in research and recruitment to studies.All NHS organisations should be offering research. And there are many ways they can achieve this – some of the universal themes, irrespective of the field. changing culturepartnering with othersintegrating research into care pathwaysExplore the website and tell us how you are doing itAn example of a project to empower patients to askDescription: When it comes to recruiting people into clinical trials and studies, the onus is often placed squarely with the consultant to ask their patients about involvement in research. However, in an environment where the consultation period is short, research can often slip off the agenda. The Dementias and Neurodegenerative Diseases Research Network (DeNDRoN) decided to look at this issue from another angle by asking whether the patient could easily be empowered to take the responsibility for asking their consultant about getting involved rather than the other way around. To do this, the network worked closely with a number of managers and service leads across their host Trust to investigate the possibility of placing a simple sentence about research involvement at the bottom of every outpatient appointment letter.Impact: The results, although impressive, were not due to patient empowerment as expected. But once again proved the importance of engaging patient facing NHS staff in research and the positive impact one small simple change can make to patient recruitment. Through altering the trust approval process and standard appointment letters, consultants were more aware of the research going on locally and referred more patients to research.
  10. A role and responsibility everyone to promote and integrate research. Talk about researchHave a conversation about research and whether they might be interested in being involved in future research.Use the UK Clinical Trials Gateway website to find out about research that might be relevant to your patients.2. Get research on the organisational agendaResearch needs to be embedded at all levels of the organisation – from the board to the ward. We need to make it a routine part of care.3. Get more involvedSign up to the Research Ready Care Home Network – see DeNDRoN websiteJoin the DeNDRoN community.Patients and carers – register your interest in being involved in research – on DeNDRoN website.